{"name":"Charlotte-Paige Rolle, MD","slug":"charlotte-paige-rolle-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill","genericName":"Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill","slug":"bictegravir-emtricitabine-tenofovir-alafenamide-pill","indication":"HIV-1 infection in treatment-naïve and treatment-experienced adults","status":"marketed"},{"name":"Dolutegravir / Lamivudine Pill","genericName":"Dolutegravir / Lamivudine Pill","slug":"dolutegravir-lamivudine-pill","indication":"HIV-1 infection in treatment-naïve and treatment-experienced adults","status":"marketed"}]}],"pipeline":[{"name":"Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill","genericName":"Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill","slug":"bictegravir-emtricitabine-tenofovir-alafenamide-pill","phase":"marketed","mechanism":"This combination pill inhibits HIV reverse transcriptase and integrase to block viral replication and prevent the virus from integrating into host cell DNA.","indications":["HIV-1 infection in treatment-naïve and treatment-experienced adults"],"catalyst":""},{"name":"Dolutegravir / Lamivudine Pill","genericName":"Dolutegravir / Lamivudine Pill","slug":"dolutegravir-lamivudine-pill","phase":"marketed","mechanism":"Dolutegravir inhibits HIV integrase to prevent viral DNA integration into the host genome, while lamivudine inhibits reverse transcriptase to block HIV replication.","indications":["HIV-1 infection in treatment-naïve and treatment-experienced adults","HIV-1 infection in adolescents and children (weight-based dosing)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxORmZBSVAtUGxUbWJXOFpiSTRxSzB0VWM0bEZYMW5iU3lKLWVrUlZwcjVuMEtjNDF2NVdOd29HTzloamFpUzFhN0Y2YTk4OTIxbXdPLVQ3Q2pTTHlUX2twWGJ5OXAyYTRHaEVhQ1BHUVkzWUVlUDBVUGU3cTNHUVF3bk9sWFU4S05Sd3BUQXdxVTN2OERJSHdyaWZFSTBIQVFyOXJBcmI1RlRuTXlPU0dSa0hVQldvUzMwNkk4?oc=5","date":"2026-03-02","type":"pipeline","source":"Aidsmap","summary":"Broadly neutralising antibody plus cabotegravir maintains viral suppression for at least a year - Aidsmap","headline":"Broadly neutralising antibody plus cabotegravir maintains viral suppression for at least a year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPRmRlcnU3NG53SFE4Z3FMSHlKdHowVDVIV05aQkM4U3NwQWpSYlZFaXRWblNKZGFKdmhPUXcwRW9RNFhGOHFlcFdCMU5kd2JLMHNpWm1PSWFjYUVBV3hlUDlvQjF4ajg2T01PYzFHZ0xpQWd1VlZLSWtCVFpmdHlpeXZGQ19TaENCU0k2aWtadjZtNy15dWNnTElIcC1RTzA4YXgyZzlIWmJLRkxZQ0hNLVE0bDA?oc=5","date":"2023-12-16","type":"pipeline","source":"respiratory-therapy.com","summary":"Telehealth for Managing Flu Patients - respiratory-therapy.com","headline":"Telehealth for Managing Flu Patients - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5WQ25pZ1ctT2NfcDNVR3FJZW9DUFIxR2haaFloNy0tczZrd1R4RjNGclMxenNKbXpMck42QTh6b1dCM0h1ZU5PTU9TdEhQR2QyNk5YbXRPZEhlWkh5V19kR2c2TjkwRjFuOWlaStIBcEFVX3lxTFBScG1xNWVyVHJzSWUxSmw4UWFxS090ZEtQYlVUTWJhYndhcGFtNWY2bVhNXzNBM3cwZktXVFBHamVtbm9CSWk3MnJIbmlqVUd1a2ZEaVdCUXBaWS05NERGdWs5aFB6UUxpM0tqT253Y3Y?oc=5","date":"2020-09-08","type":"pipeline","source":"koreabiomed.com","summary":"GSK proves Dovato’s rapid treatment efficacy on adult HIV patients - koreabiomed.com","headline":"GSK proves Dovato’s rapid treatment efficacy on adult HIV patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTFBmcVZYaGs3QzRsdFVOUW5FTmkxTDY1SXQtUzNrRURFVDFYd0ZqVlZwSnk1NXlKeGJibFh2aWhwaklEbkFJTUMyR3hCcHAxSUszUGs1cUdDd3p5Q2syN1c1aGRkMjZvVk1RMExjanBpa1gxOGM?oc=5","date":"2020-08-07","type":"regulatory","source":"poz.com","summary":"FDA Approves Dovato as HIV Switch Option - poz.com","headline":"FDA Approves Dovato as HIV Switch Option","sentiment":"positive"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}